Search Results

Recent Patents on Positive Allosteric Modulators of the Metabotropic Glutamate 5 Receptor as a Potential Treatment for Schizophrenia

Authors: Kanuma, Kosuke; Aoki, Takeshi; Shimazaki, Youichi

Source: Recent Patents on CNS Drug Discovery, Volume 5, Number 1, January 2010 , pp. 23-34(12)

Publisher: Bentham Science Publishers

“Hearing voices”: Auditory hallucinations as failure of top-down control of bottom-up perceptual processes

Author: HUGDAHL, KENNETH

Source: Scandinavian Journal of Psychology, Volume 50, Number 6, December 2009 , pp. 553-560(8)

Publisher: Blackwell Publishing

From bench to bedside: translating new research from genetics and neuroimaging into treatment development for early-onset schizophrenia

Authors: Kumra, Sanjiv; Asarnow, Robert; Grace, Anthony; Keshavan, Matcheri; McClellan, Jon; Sikich, Linmarie; Wagner, Ann

Source: Early Intervention in Psychiatry, Volume 3, Number 4, November 2009 , pp. 243-258(16)

Publisher: Blackwell Publishing

A comparison of early psychosis treatment services using consensus and evidence-based performance measures: moving towards setting standards

Authors: Addington, Donald; Norman, Ross; Adair, Carol E.; Manchanda, Rahul; McKenzie, Emily; Mitchell, Beth; Pryce, Cathy

Source: Early Intervention in Psychiatry, Volume 3, Number 4, November 2009 , pp. 274-281(8)

Publisher: Blackwell Publishing

Improving detection of first-episode psychosis by mental health-care services using a self-report questionnaire

Authors: Boonstra, Nynke; Wunderink, Lex; Sytema, Sjoerd; Wiersma, Durk

Source: Early Intervention in Psychiatry, Volume 3, Number 4, November 2009 , pp. 289-295(7)

Publisher: Blackwell Publishing

`Schizophrenia postdrome': a study of low-level psychotic experience after remission of first-episode schizophrenia

Authors: Burley, Kate; Upthegrove, Rachel; Birchwood, Max; Patterson, Paul; Skeate, Amanda

Source: Early Intervention in Psychiatry, Volume 3, Number 4, November 2009 , pp. 296-299(4)

Publisher: Blackwell Publishing

Diet blues: Methodological problems in comparing non-pharmacological weight management programs for patients with schizophrenia

Authors: Veit, Tina; Barnas, Christian

Source: International Journal of Psychiatry in Clinical Practice, Volume 13, Number 3, September 2009 , pp. 173-183(11)

Publisher: Informa Healthcare

Effectiveness and tolerability of long-acting risperidone: A 9-month open-label extension of a 12-week switching study from oral antipsychotics

Authors: Kim, Chang Yoon; Chung, Seockhoon; Hahm, Bong-Jin; Hong, Kyung Sue; Yoon, Jin-Sang; Kim, Young-Hoon; Bahk, Won-Myong; Lee, Sang-Yeol; Lee, Yanghyun; Chung, In-Won; Kim, Chan-Hyung

Source: International Journal of Psychiatry in Clinical Practice, Volume 13, Number 3, September 2009 , pp. 192-198(7)

Publisher: Informa Healthcare

Comparison of plasma levels between oral solution and fine granule dosage forms of risperidone

Authors: Yoda, Hiroo; Yamashita, Hakuei

Source: International Journal of Psychiatry in Clinical Practice, Volume 13, Number 3, September 2009 , pp. 199-205(7)

Publisher: Informa Healthcare

Strategies used by psychotic individuals to cope with life stress and symptoms of illness: a systematic review

Authors: Phillips, Lisa; Francey, Shona; Edwards, Jane; McMurray, Nancy

Source: Anxiety, Stress and Coping, Volume 22, Number 4, July 2009 , pp. 371-410(40)

Publisher: Routledge, part of the Taylor & Francis Group

Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders

Authors: Bacher, Ingrid; Wu, Becky; Shytle, Douglas R; George, Tony P

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 16, November 2009 , pp. 2709-2721(13)

Publisher: Informa Healthcare

Associations between the Illness Perception Questionnaire for Schizophrenia and engagement in treatment in a secure setting

Authors: Shah, Prveen; Hull, Tim; Riley, Gerard Anthony

Source: Clinical Psychologist, Volume 13, Number 2, July 2009 , pp. 69-74(6)

Publisher: Taylor and Francis Ltd

Schizophrenia, obsessive covert mental rituals and social anxiety: Case report

Authors: Tully, Phillip; Edwards, Christopher

Source: Clinical Psychologist, Volume 13, Number 2, July 2009 , pp. 75-77(3)

Publisher: Taylor and Francis Ltd

Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies

Authors: Bushe, C. J.; Bradley, A. J.; Doshi, S.; Karagianis, J.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1743-1761(19)

Publisher: Blackwell Publishing

Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic

Author: Citrome, L.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1762-1784(23)

Publisher: Blackwell Publishing

The experiences of carers in Taiwanese culture who have long-term schizophrenia in their families: a phenomenological study

Authors: HUANG, X.-Y.; HUNG, B.-J.; SUN, F. K.; LIN, J.-D.; CHEN, C.-C.

Source: Journal of Psychiatric & Mental Health Nursing, Volume 16, Number 10, December 2009 , pp. 874-883(10)

Publisher: Blackwell Publishing

Exploring the role of face processing in facial emotion recognition in schizophrenia

Authors: Rocca, Paola; Castagna, Filomena; Mongini, Tullia; Montemagni, Cristiana; Rasetti, Roberta; Rocca, Giuseppe; Bogetto, Filippo

Source: Acta Neuropsychiatrica, Volume 21, Number 6, December 2009 , pp. 292-300(9)

Publisher: Blackwell Publishing

Progressive brain changes in schizophrenia: a 1-year follow-up study of diffusion tensor imaging

Authors: Ota, Miho; Obu, Satoko; Sato, Noriko; Mizukami, Katsuyoshi; Asada, Takashi

Source: Acta Neuropsychiatrica, Volume 21, Number 6, December 2009 , pp. 301-307(7)

Publisher: Blackwell Publishing

Autism genetics: emerging data from genome-wide copy-number and single nucleotide polymorphism scans

Author: Weiss, Lauren A

Source: Expert Review of Molecular Diagnostics, Volume 9, Number 8, November 2009 , pp. 795-803(9)

Publisher: Expert Reviews

Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?

Author: Hashimoto, Kenji

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 470-474(5)

Publisher: Bentham Science Publishers